(-0.16%) 5 460.59 points
(-0.34%) 38 979 points
(0.20%) 17 753 points
(0.14%) $80.94
(-3.48%) $2.66
(-0.98%) $2 308.00
(-0.44%) $28.74
(1.26%) $998.80
(0.25%) $0.936
(0.84%) $10.69
(0.36%) $0.791
(-0.28%) $87.24
Live Chart Being Loaded With Signals
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics...
Stats | |
---|---|
本日の出来高 | 200 |
平均出来高 | 12 587 |
時価総額 | 0.00 |
EPS | $-2.46 ( Q1 | 2024-05-10 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0530 (18.29%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-08 | Tidmarsh George F | Sell | 27 771 | Common Stock |
2023-10-16 | Tidmarsh George F | Sell | 1 845 | Common Stock |
2023-10-16 | Tidmarsh George F | Sell | 10 957 | Common Stock |
2023-09-27 | Chawla Lakhmir S | Buy | 0 | |
2023-09-28 | Tidmarsh George F | Sell | 1 429 | Common Stock |
INSIDER POWER |
---|
-15.58 |
Last 48 transactions |
Buy: 316 523 | Sell: 2 020 596 |
ボリューム 相関
Revelation Biosciences, 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Revelation Biosciences, 相関 - 通貨/商品
Revelation Biosciences, 財務諸表
Annual | 2023 |
収益: | $0 |
総利益: | $-25 049.00 (0.00 %) |
EPS: | $-0.530 |
FY | 2023 |
収益: | $0 |
総利益: | $-25 049.00 (0.00 %) |
EPS: | $-0.530 |
FY | 2022 |
収益: | $0 |
総利益: | $-40 008.00 (0.00 %) |
EPS: | $-600.77 |
FY | 2021 |
収益: | $0.00 |
総利益: | $0.00 (0.00 %) |
EPS: | $-0.310 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Revelation Biosciences,
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal congestion and allergic rhinitis; and REVTx-200, a nonclinical stage product for intranasal therapy. It is also involved in developing REVTx-300, a non-clinical stage product that is being developed as a potential therapy for the treatment of chronic organ disease, including chronic kidney disease and non-alcoholic steatohepatitis; and REVDx-501, a rapid test kit, which is a point of care in vitro diagnostic test that has the potential to detect respiratory viral infections, such as SARS-CoV-2, Influenza A, Influenza B, parainfluenza, or respiratory syncytial virus. The company was founded in 2020 and is based in San Diego, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。